P50 NS123067/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	4
2021	11
2022	22
2023	13
2024	5

1

Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches.

Bohnen NI, Yarnall AJ, Weil RS, Moro E, Moehle MS, Borghammer P, Bedard MA, Albin RL. Bohnen NI, et al. Lancet Neurol. 2022 Apr;21(4):381-392. doi: 10.1016/S1474-4422(21)00377-X. Epub 2022 Feb 4. Lancet Neurol. 2022. PMID: 35131038 Free PMC article. Review.

2

Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.

Albin RL, van der Zee S, van Laar T, Sarter M, Lustig C, Muller MLTM, Bohnen NI. Albin RL, et al. Prog Brain Res. 2022;269(1):345-371. doi: 10.1016/bs.pbr.2022.01.011. Epub 2022 Feb 4. Prog Brain Res. 2022. PMID: 35248201 Free PMC article. Review.

3

Imaging of sleep disorders in pre-Parkinsonian syndromes.

Ota Y, Kanel P, Bohnen N. Ota Y, et al. Curr Opin Neurol. 2022 Aug 1;35(4):443-452. doi: 10.1097/WCO.0000000000001084. Epub 2022 Jul 5. Curr Opin Neurol. 2022. PMID: 35788559 Free PMC article. Review.

4

Update: Descriptive epidemiology of Parkinson disease.

Grotewold N, Albin RL. Grotewold N, et al. Parkinsonism Relat Disord. 2024 Mar;120:106000. doi: 10.1016/j.parkreldis.2024.106000. Epub 2024 Jan 8. Parkinsonism Relat Disord. 2024. PMID: 38233324 Review.

5

Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.

Schumacher J, Kanel P, Dyrba M, Storch A, Bohnen NI, Teipel S, Grothe MJ. Schumacher J, et al. Brain. 2023 Dec 1;146(12):4964-4973. doi: 10.1093/brain/awad226. Brain. 2023. PMID: 37403733

6

Discussion of Research Priorities for Gait Disorders in Parkinson's Disease.

Bohnen NI, Costa RM, Dauer WT, Factor SA, Giladi N, Hallett M, Lewis SJG, Nieuwboer A, Nutt JG, Takakusaki K, Kang UJ, Przedborski S, Papa SM; MDS-Scientific Issues Committee. Bohnen NI, et al. Mov Disord. 2022 Feb;37(2):253-263. doi: 10.1002/mds.28883. Epub 2021 Dec 22. Mov Disord. 2022. PMID: 34939221 Free PMC article. Review.

7

Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.

Slingerland S, van der Zee S, Carli G, Slomp AC, Boertien JM, d'Angremont E, Bohnen NI, Albin RL, van Laar T. Slingerland S, et al. Brain. 2024 Mar 1;147(3):900-910. doi: 10.1093/brain/awad323. Brain. 2024. PMID: 37748026 Free PMC article.

8

Repeat RNA Toxicity Drives Ribosomal RNA Processing Defects in SCA2.

Skariah G, Albin RL. Skariah G, et al. Mov Disord. 2021 Nov;36(11):2464-2467. doi: 10.1002/mds.28795. Mov Disord. 2021. PMID: 34783387 Free PMC article. No abstract available.

9

Cholinergic system correlates of postural control changes in Parkinson's disease freezers.

Roytman S, Paalanen R, Griggs A, David S, Pongmala C, Koeppe RA, Scott PJH, Marusic U, Kanel P, Bohnen NI. Roytman S, et al. Brain. 2023 Aug 1;146(8):3243-3257. doi: 10.1093/brain/awad134. Brain. 2023. PMID: 37086478 Free PMC article.

10

Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements.

Sarter M, Avila C, Kucinski A, Donovan E. Sarter M, et al. Mov Disord. 2021 Mar;36(3):535-546. doi: 10.1002/mds.28532. Epub 2021 Feb 22. Mov Disord. 2021. PMID: 33615556 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year